Update on Transcatheter Aortic Valve Implantation

Corina Biagioni, *Pablo Salinas, Luis Nombela-Franco,  Pilar Jimenez-Quevedo

Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain
*Correspondence to salinas.pablo@gmail.com

Disclosure: The authors have declared no conflicts of interest.
Received: 27.01.16 Accepted: 29.04.16
Citation: EMJ Int Cardiol. 2016;4[1]:91-99.

Abstract

Aortic valve replacement is the mainstay of treatment for symptomatic severe aortic stenosis. In this  setting, the rapidly evolving field of transcatheter aortic valve implantation (TAVI) is currently considered a safe alternative to surgical aortic valve replacement in patients with severe aortic stenosis who are  considered inoperable or at high surgical risk. This review will focus on recent changes in the field of TAVI, describing patient selection, valve types, procedural approaches, short and long-term outcomes, and complications. The rapid evolution of TAVI procedures supported by solid evidence will, in the near future, probably extend the indications to a wider portion of patients with aortic stenosis.

Download (PDF, 151KB)

Comments are closed.